Clinical Trial Update: Study Evaluating ERB-041 With Methotrexate in Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating ERB-041 in combination with methotrexate for rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ERB-041
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED